Tags: KIMMTRAKNICEuveal melanomamelanomabiomarker
| Profile | Contacts | Recent Articles on Subject | |
|---|---|---|---|
| 1 | Frank Vinluan MedCity News Medical innovation tracker. MedCity, USA | ||
| 2 | Kristen Monaco MedPage Today | ||
| 3 | John Pinching PharmaTimes Next-gen biopharma company. La Jolla, California | AMBLor prognostic melanoma biomarker receives UKCA Mark - 6 months ago | |
| 4 | Mike Bassett MedPage Today Explains healthcare complexities. Not endorsements. New York, New York | A Blenrep Comeback? Cancer Vaccine for Dogs; U.K. Snubs Enhertu - 12 months ago Two Pembrolizumab Trials in Head and Neck Cancer Yield Divergent Results - about 1 year ago FDA OKs First Cellular Therapy for Melanoma - about 1 year ago | |
| 5 | Alana Hippensteele, Managing Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey | ||
| 6 | Kennedy Ferruggia, Assistant Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey | ||
| 7 | Greg Laub MedPage Today Director of Video at MedPage Today. Screenwriter, previous managing editor. | Breast Cancer Highlights From ASCO 2024 - 9 months ago | |
| 8 | Randy Dotinga MedPage Today Indie scribbler, advocate.
Board member, @ahcj. San Diego | ||
| 9 | Meghana Keshavan STAT News Biotech nerd and writer @statnews. | The latest updates on cancer research from the weekend - 11 months ago | |
| 10 | <em>The Scientist</em> Staff The Scientist Exploring Life, Inspiring Innovation. | Defining the Triple Negative Breast Cancer Morpholome - about 1 year ago |